Monkeypox: Why It's Still a Concern in 2024

Monkeypox: Why It's Still a Concern in 2024

Monkeypox, once considered a rare zoonotic disease, has re-emerged as a global health concern. Despite initial containment efforts in 2022, sporadic outbreaks continue to occur, particularly in non-endemic regions. This post explores why monkeypox remains a threat and what you need to know.

What Is Monkeypox?

Monkeypox is a viral disease caused by the monkeypox virus, a member of the Orthopoxvirus family. It shares similarities with smallpox but is generally milder. Transmission occurs through close contact with infected animals or humans, respiratory droplets, or contaminated objects.

Why Is It Still a Concern?

1. Global Spread: While initially confined to Central and West Africa, monkeypox has now been reported in over 100 countries.
2. Delayed Diagnosis: Symptoms like fever, rash, and swollen lymph nodes can mimic other illnesses, leading to delayed diagnosis.
3. Community Transmission: Sustained human-to-human transmission has been observed, especially in densely populated areas.

Management and Prevention

Clinical Features The illness typically begins with fever, headache, and muscle aches, followed by a distinctive rash that progresses through stages—macules, papules, vesicles, pustules, and scabs.

Prevention Measures - Vaccination: The smallpox vaccine provides cross-protection against monkeypox. High-risk groups should consider vaccination. - Isolation: Infected individuals should isolate until all lesions have healed. - Hygiene: Regular handwashing and disinfection of surfaces can reduce transmission.

Red Flags to Watch For

• Severe complications like encephalitis or secondary bacterial infections.
• Rapid progression of symptoms in immunocompromised individuals.

Sources This post reflects guidance from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).